These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6756010)

  • 1. Impaired subcutaneous absorption of insulin in 'brittle' diabetics.
    Home PD; Massi-Benedetti M; Gill GV; Capaldo B; Shepherd GA; Alberti KG
    Acta Endocrinol (Copenh); 1982 Nov; 101(3):414-20. PubMed ID: 6756010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion.
    Massi Benedetti M; Home PD; Gill GV; Burrin JM; Noy GA; Alberti KG
    Diabetes Res Clin Pract; 1987; 3(6):307-17. PubMed ID: 3311678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes.
    Capaldo B; Home PD; Massi-Benedetti M; Worth R; Cook DB; Heaton A; Alberti KG
    Diabetes Res; 1984 Nov; 1(4):187-93. PubMed ID: 6397293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
    Stevenson RW; Orskov H; Parsons JA; Alberti KG
    Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
    Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
    Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.
    Madsbad S; Faber OK; Binder C; Alberti KG; Lloyd B
    Acta Diabetol Lat; 1981; 18(2):115-21. PubMed ID: 7018146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.
    Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS
    Lancet; 1979 Jun; 1(8129):1255-7. PubMed ID: 87724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.
    Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG
    Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy.
    Viberti GC; Home PD; Bilous RW; Alberti KG; Dalton N; Keen H; Pickup JC
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):515-20. PubMed ID: 6372348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
    Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ
    Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity in hyperthyroidism: measurement by the glucose clamp technique.
    McCulloch AJ; Home PD; Heine R; Ponchner M; Hanning I; Johnston DG; Clark F; Alberti KG
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):327-33. PubMed ID: 6347438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
    Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
    Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.
    Pickup JC; Viberti GC; Bilous RW; Keen H; Alberti KG; Home PD; Binder C
    Diabetologia; 1982 Mar; 22(3):175-9. PubMed ID: 7042428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of exercise-induced hypoglycaemia in type i (insulin-dependent) diabetic patients during maintenance of normoglycaemia by short-term, open-loop insulin infusion.
    Martin MJ; Robbins DC; Bergenstal R; LaGrange B; Rubenstein AH
    Diabetologia; 1982 Oct; 23(4):336-42. PubMed ID: 6754517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic response to moderate exercise in diabetic man receiving intravenous and subcutaneous insulin.
    Murray FT; Zinman B; McClean PA; Denoga A; Albisser AM; Leibel BS; Nakhooda AF; Stokes EF; Marliss EB
    J Clin Endocrinol Metab; 1977 Apr; 44(4):708-20. PubMed ID: 849981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
    Krzentowski G; Scheen A; Castillo M; Luyckx AS; Lefèbvre PJ
    Diabetologia; 1983 May; 24(5):314-8. PubMed ID: 6347779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.